ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

BVXV BiondVax Pharmaceuticals Ltd

1,36
0,00 (0,00%)
26 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
BiondVax Pharmaceuticals Ltd BVXV NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,36 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,36 1,36
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202423:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.4.202413:00PRNUSScinai to showcase its novel biological local therapeutic..
12.3.202421:17EDGAR2Form SC 13D - General statement of acquisition of beneficial..
12.3.202413:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
13.2.202413:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development..
04.1.202422:01PRNUSScinai Immunotherapeutics Announces Closing of Exercise of..
20.11.202313:30PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq's..
07.9.202323:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06.9.202318:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.9.202317:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.9.202312:00GLOBEBiondVax Pharmaceuticals Ltd. Rebrands as Scinai..
28.8.202322:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
28.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
24.8.202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23.8.202312:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18.8.202322:16EDGAR2Form F-3 - Registration statement by foreign private issuers
18.8.202316:07EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
14.8.202312:08EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
11.8.202315:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.8.202315:00GLOBEBiondVax Reports Second Quarter Financial Results and..
01.8.202322:01GLOBENasdaq Grants BiondVax Extension to Regain Compliance with..
01.8.202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.7.202321:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.7.202314:17GLOBEIBN Announces Latest Episode of The Bell2Bell Podcast..
05.7.202315:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.7.202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.7.202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.6.202313:00GLOBEBiondVax signs exclusive license agreement for development..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock